Jan 17 (Reuters) - Incannex Healthcare Inc IQI0y.F : INCANNEX HEALTHCARE:RECEIVES IRB APPROVAL FOR REPOSA PHASE 2/3 CLINICAL TRIAL PROTOCOL TO ASSESS IHL-42X DRUG IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (([email protected];))